Long-term effects of pegvisomant in patients with acromegaly
Nature Clinical Practice Endocrinology & Metabolism · 2008-06 · 4 (6) · 324-332
DOI: 10.1038/ncpendmet0831 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nature Clinical Practice Endocrinology & Metabolism, online erschienen am 22.04.2008. Verfasst von Israel Hodish und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Division of Metabolism, Endocrinology and Diabetes, University of Michigan Medical Center and the Veterans' Affairs …. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 61 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Division of Metabolism, Endocrinology and Diabetes, University of Michigan Medical Center and the Veterans' Affairs Medical Center, Ann Arbor, MI, USA.
Zitieren
APA
Hodish, I., & Barkan, A. (2008). Long-term effects of pegvisomant in patients with acromegaly. Nature Clinical Practice Endocrinology & Metabolism, 4(6), 324-332. https://doi.org/10.1038/ncpendmet0831
Vancouver
Hodish I, Barkan A. Long-term effects of pegvisomant in patients with acromegaly. Nature Clinical Practice Endocrinology & Metabolism. 2008;4(6):324-332. doi:10.1038/ncpendmet0831
BibTeX
@article{Hodish2008,
author = {Hodish, Israel and Barkan, Ariel},
title = {Long-term effects of pegvisomant in patients with acromegaly},
journal = {Nature Clinical Practice Endocrinology & Metabolism},
year = {2008},
volume = {4},
number = {6},
pages = {324--332},
doi = {10.1038/ncpendmet0831}
}
EUVIMED